Bris­tol My­ers, Ideaya tout da­ta in sol­id tu­mors with cer­tain ge­net­ic mu­ta­tions

Bris­tol My­ers Squibb and Ideaya Bio­sciences both re­leased de­tailed snap­shots of ear­ly-stage da­ta for can­cer drugs tar­get­ing sol­id tu­mors with a cer­tain mu­ta­tion known as …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER